Medical Device Industry News

Abiomed jumps on FDA deal for Impella indication

October 30, 2014 by Brad Perriello

Abiomed says it's come to an agreement with the FDA on an indication for its flagship Impella 2.5 heart pump, and now expects to win pre-market approval early next year without a hearing before an FDA advisory panel.

Abiomed jumps on deal with FDA

Medtronic, Covidien merger expected to close in 2015

October 30, 2014 by Brad Perriello

Medtronic and Covidien say their pending, $43 billion merger is expected to close in early 2015.

Medtronic, Covidien merger expected to close in 2015

MassDevice.com +3 | The top 3 medtech stories for October 29, 2014

October 29, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Creganna-Tactx Medical acquires Precision Wire Components

October 29, 2014 by Brad Perriello

Creganna-Tactx Medical pays an unspecified amount to acquire Precision Wire Components and rebrands as Creganna Medical.

Creganna-Tactx Medical acquires Precision Wire Components

Irish medical device outsourcer Creganna-Tactx Medical said today that it agreed to acquire Precision Wire Components LLC for an unspecified amount, saying it will re-brand as Creganna Medical.

Aethlon to provide Hemopurifier to treat Ebola in U.S.

October 29, 2014 by Val Kennedy

Aethlon Medical plans to make its Hemopurifier blood-filtration device available to U.S. healthcare providers for the treatment of Ebola under the FDA's compassionate use provision.

Aethlon to provide Hemopurifier to treat Ebola in U.S.

Biomet inks $6m deal to settle kickback charges

October 29, 2014 by Brad Perriello

Biomet agrees to pay more than $6 million to settle False Claims Act charges that it paid doctors to use its bone-growth stimulators.

Biomet inks $6m deal to settle FCA charges

Biomet paid nearly $6.1 million to settle federal charges that it paid kickbacks to doctors to induce them to use bone growth stimulators sold by its EBI subsidiary, the U.S. Justice Dept. said today.

Report: Google's working on a cancer-detecting pill

October 29, 2014 by Brad Perriello

Google is reportedly developing a pill designed to use nanoparticles to detect cancer and other conditions.

Report: Google's working on a cancer-detecting pill

Google (NSDQ:GOOG) is reportedly working on a pill designed to use magnetized nanoparticles to detect cancer and other conditions.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp